Physician profile
Bryan Kavanaugh
NPI 1346452273
$706.26
in general payments reported to CMS, 2019-2025
14 companies · $221 in 2025
The $221 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2022: $103 · 2023: $58.20 · 2024: $46.13 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $149.46 | 2019-2024 | |
| W. L. Gore & Associates, INC. | $148.48 | 2019 | |
| Olympus America INC. | $109.32 | 2019-2025 | Single Use Aspiration Needle Na-U200h, Endoclot Phs |
| Boston Scientific Corporation | $102.95 | 2025 | Resolution 360 Clip |
| Pfizer INC. | $36.05 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $23.63 | 2024 | Zeposia |
| Genzyme Corporation | $23.08 | 2025 | |
| Ironwood Pharmaceuticals, INC | $22.16 | 2022 | |
| Enterra Medical, INC. | $20.60 | 2022 | |
| Allergan, INC. | $19.00 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.41 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.32 | 2019 | |
| Celgene Corporation | $16.80 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Kavanaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.